ka hona mona ke Lethathamo la lik'hamphani tse holimo tsa Biotech tsa Jeremane tse hlophisitsoeng ho ipapisitse le kakaretso ea chelete.
| S / N | Lebitso la K'hamphani | Kakaretso ea Chelete (FY) | Palo ea basebetsi ba |
| 1 | Morphosys Ag | $ Limilione tse 401 | 615 |
| 2 | Brain Biotec Na | $ Limilione tse 45 | 279 |
| 3 | Formycon Ag | $ Limilione tse 42 | 131 |
| 4 | Biofrontera Ag Na | $ Limilione tse 37 | 149 |
| 5 | Vita 34 Ag Na | $ Limilione tse 25 | 116 |
| 6 | Heidelberg Pharma Ag | $ Limilione tse 10 | 84 |
| 7 | Medigene Ag Na | $ Limilione tse 10 | 121 |
| 8 | 4Sc Ag Inh. | $ Limilione tse 3 | 48 |
Morphosys Ag
MorphoSys AG e sebetsa joalo ka k'hamphani ea boemo ba khoebo ea biopharmaceutical. Khampani e shebane le ho sibolloa, nts'etsopele le phano ea meriana e ncha ea mofetše. MorphoSys e sebeletsa bareki lefatšeng ka bophara.
BRAIN Biotech AG
BRAIN Biotech AG ke khamphani ea theknoloji, e ikamahanyang le nts'etsopele le khoebo ea bioactives, metsoako ea tlhaho, le li-enzyme tse amanang le tsona. E sebetsa ka likarolo tsa BioScience le BioIndustrial.
Karolo ea BioScience e sebetsa ho li-enzyme le likokoana-hloko tsa ts'ebetso; le ho sebelisana 'moho le balekane ba indasteri. Karolo ea BioIndustrial e sebetsana le likhoebo tsa bioproduct le litlolo. Khamphani e thehiloe ke Holger Zinke, Jüngen Eck, le Hans Günter Gassen ka la 22 Loetse 1993 'me e na le ntlo-kholo ea eona Zwingenberg, Jeremane.
Formycon
Formycon ke mohlahisi ea etelletseng pele, ea ikemetseng oa meriana ea boleng bo holimo ea biopharmaceutical, haholo li-biosimilars. Khamphani e tsepamisitse maikutlo liphekolong tsa ophthalmology, immunology le mafu a mang a bohlokoa a sa foleng, a koahelang ketane eohle ea boleng ho tloha ho nts'etsopele ea tekheniki ho isa karolong ea III ea bongaka hammoho le ho lokisoa ha li-dossier bakeng sa tumello ea ho bapatsa.
Ka li-biosimilars tsa eona, Formycon e kenya letsoho haholo molemong oa ho fa bakuli ba bangata kamoo ho ka khonehang monyetla oa ho fumana meriana ea bohlokoa le e theko e tlase. Formycon hajoale e na le li-biosimilars tse tšeletseng ho nts'etsopele. Ho ipapisitsoe le boiphihlelo ba eona bo batsi ho nts'etsopele ea lithethefatsi tsa biopharmaceutical, k'hamphani e ntse e sebetsa ho nts'etsopele ea sethethefatsi sa COVID-19 FYB207.
Biofrontera Ag Na
Biofrontera AG ke k'hamphani ea biopharmaceutical e sebetsanang le nts'etsopele le thekiso ea lithethefatsi tsa letlalo le litlolo tsa bongaka. Khampani e thehiloeng ho Leverkusen e hlahisa le ho rekisa lihlahisoa tse ncha bakeng sa phekolo, tšireletso le tlhokomelo ea letlalo.
Lihlahisoa tsa eona tsa bohlokoa li kenyelletsa Ameluz®, setlhare se fanoeng ke ngaka bakeng sa kalafo ea mofets'e oa letlalo o se nang melanoma le li-precursor tsa ona. Ameluz® e 'nile ea rekisoa EU ho tloha 2012 le USA ho tloha ka May 2016. Europe, k'hamphani e boetse e rekisa letoto la Belixos® dermocosmetic, sehlahisoa sa tlhokomelo e khethehileng bakeng sa letlalo le senyehileng. Biofrontera ke e 'ngoe ea Majeremane a seng makae k'hamphani ea meriana ho fumana tumello ea Europe le US bakeng sa sethethefatsi se entsoeng ka tlung. Sehlopha sa Biofrontera se thehiloe ka 1997 mme se thathamisitsoe ho Frankfurt Stock Exchange (Prime Standard).
Vita 34 Ag Na
E thehiloe Leipzig ka 1997 e le mali a pele a poraefete a mokhubu banka Europe, Vita 34 ke mofani oa thepa e felletseng ea "cryo-preservation" mme e fana ka lisebelisoa tsa ho bokella mali, ho lokisoa le ho boloka lisele tsa stem ho tsoa maling le liseleng tsa mokhubu.
Lisele tsa stem ke mohloli oa bohlokoa bakeng sa kalafo ea lisele tsa bongaka. Li bolokiloe li phela mochesong oa likhato tse ka bang 180 tsa Celsius hore li khone ho li sebelisa sebakeng sa kalafo ea bongaka, ha ho hlokahala. Bareki ba fetang 230.000 ba tsoang Jeremane le linaheng tse ling tsa 20 ba se ba buletse li-stem cell deposits le Vita 34, kahoo ba fana ka bophelo bo botle ba bana ba bona.
Heidelberg Pharma Ag
Heidelberg Pharma AG ke k'hamphani ea biopharmaceutical e sebetsang lefapheng la oncology. Khamphani e tsepamisitse maikutlo ho nts'etsopele ea Antibody Drug Conjugates (ADCs) bakeng sa kalafo ea mafu a oncological. Li-ATAC tsa Heidelberg Pharma ke li-ADC tse ipapisitseng le theknoloji ea ATAC e sebelisang Amanitin joalo ka motsoako o sebetsang. Mokhoa oa tlhaho oa ts'ebetso ea chefo ea Amanitin e emela molao-motheo o mocha oa phekolo.
Sethala sena sa beng ba thepa se ntse se sebelisoa ho nts'etsapele li-ATAC tsa Khampani tsa kalafo le litšebelisano tsa batho ba boraro ho theha bonkgetheng ba fapaneng ba ATAC. Mokhethoa ea etellang pele HDP-101 ke BCMA-ATAC bakeng sa myeloma e mengata. Bakhethoa ba bang ba ntlafatso ea pele ke HDP-102, CD37 ATAC bakeng sa Non-Hodgkin lymphoma le HDP-103, PSMA ATAC bakeng sa mofetše oa tšoelesa ea senya.
K'hamphani hammoho le tlatsetso ea eona ea Heidelberg Pharma Research GmbH e thehiloe Ladenburg haufi le Heidelberg Jeremane. E thehiloe ka Loetse 1997 e le Wilex Biotechnology GmbH mane Munich mme e fetotsoe ho WILEX AG ka 2000. Ka 2011, ho ile ha fumanwa setsi sa tlasana sa Heidelberg Pharma Research GmbH mme kamora tokiso, ofisi e ngodisitsweng ya WILEX AG e ile ya tloswa Munich ho ya Ladenburg mme lebitso la Khampani le fetotsoe ho Heidelberg Pharma AG.
Lefapha la tlatsetso la Heidelberg Pharma GmbH le se le bitsoa Heidelberg Pharma Research GmbH. Heidelberg Pharma AG e thathamisitsoe ho Frankfurt Stock Exchange 'marakeng o laoloang / Prime Standard.
